Scientists at the University of Texas Southwestern Medical Center said they found injections of the drug rituximab (Rituxan, MabThera) help slow the destruction of insulin-producing beta cells in the pancreas of those newly diagnosed with type 1 diabetes, suggesting a potential treatment option that might improve management and reduce long-term complications of the disease.
Dr. Philip Raskin, a professor of internal medicine at UT Southwestern, called the findings "extremely exciting."
"Our findings in no way suggest that rituximab should be used as a treatment or that it will eliminate the need for daily insulin injections," Raskin said. "This is not a cure for type 1 diabetes. The results do, however, provide evidence that B cells play a significant role in type 1 diabetes and that selective suppression of these B cells may deter the destruction of the body's beta cells."
Raskin is a co-author of the study that's reported in the New England Journal of Medicine.
Millions of Getty images now available for free via embed tool
Boston schools pull out free condoms over wrapping complaints